Cargando…

P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates

Detalles Bibliográficos
Autor principal: Franchini, G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767932/
http://dx.doi.org/10.1186/1742-4690-6-S3-P415
_version_ 1782173411787669504
author Franchini, G
author_facet Franchini, G
author_sort Franchini, G
collection PubMed
description
format Text
id pubmed-2767932
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27679322009-10-28 P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates Franchini, G Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767932/ http://dx.doi.org/10.1186/1742-4690-6-S3-P415 Text en Copyright © 2009 Franchini; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Franchini, G
P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title_full P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title_fullStr P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title_full_unstemmed P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title_short P19-51 LB. Improvement of the efficacy of ALVAC-HIV vaccine candidates for humans in non human primates
title_sort p19-51 lb. improvement of the efficacy of alvac-hiv vaccine candidates for humans in non human primates
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767932/
http://dx.doi.org/10.1186/1742-4690-6-S3-P415
work_keys_str_mv AT franchinig p1951lbimprovementoftheefficacyofalvachivvaccinecandidatesforhumansinnonhumanprimates